Achyut Healthcare Ltd
₹ 48.2
19.94%
03 May
4:01 p.m.
About
Incorporated in 1996, Achyut Healthcare Ltd is a pharmaceutical trading company dealing in API, Pharmaceutical products, medical devices, etc.[1]
Key Points
- Market Cap ₹ 81.2 Cr.
- Current Price ₹ 48.2
- High / Low ₹ 60.8 / 34.4
- Stock P/E 325
- Book Value ₹ 10.6
- Dividend Yield 0.00 %
- ROCE 2.63 %
- ROE 1.95 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Debtor days have improved from 144 to 36.5 days.
Cons
- Stock is trading at 4.57 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 1.68% over last 3 years.
- Working capital days have increased from 692 days to 1,257 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|
0.67 | 0.33 | 0.27 | 4.05 | 2.70 | 2.29 | |
0.66 | 0.32 | 0.26 | 4.08 | 2.97 | 2.55 | |
Operating Profit | 0.01 | 0.01 | 0.01 | -0.03 | -0.27 | -0.26 |
OPM % | 1.49% | 3.03% | 3.70% | -0.74% | -10.00% | -11.35% |
0.00 | 0.01 | 0.00 | 0.14 | 0.59 | 0.68 | |
Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 |
Profit before tax | 0.01 | 0.02 | 0.01 | 0.10 | 0.31 | 0.42 |
Tax % | 300.00% | 0.00% | 0.00% | 60.00% | 25.81% | |
-0.01 | 0.01 | 0.01 | 0.04 | 0.23 | 0.25 | |
EPS in Rs | -0.25 | 0.25 | 0.25 | 0.04 | 0.16 | 0.18 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 102% |
TTM: | -29% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 184% |
TTM: | 32% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | -7% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 2% |
Last Year: | 2% |
Balance Sheet
Figures in Rs. Crores
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|
Equity Capital | 0.25 | 0.25 | 0.25 | 6.74 | 9.35 | 14.02 |
Reserves | -0.05 | -0.04 | 0.00 | 2.34 | 5.18 | 0.77 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
0.04 | 0.06 | 0.25 | 0.86 | 0.81 | 0.34 | |
Total Liabilities | 0.24 | 0.27 | 0.50 | 9.94 | 15.34 | 15.13 |
0.00 | 0.00 | 0.00 | 0.03 | 0.05 | 0.05 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 3.49 | 7.04 |
Investments | 0.00 | 0.00 | 0.00 | 1.70 | 1.30 | 0.22 |
0.24 | 0.27 | 0.50 | 8.21 | 10.50 | 7.82 | |
Total Assets | 0.24 | 0.27 | 0.50 | 9.94 | 15.34 | 15.13 |
Cash Flows
Figures in Rs. Crores
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|
-0.03 | -0.02 | 0.01 | -6.96 | -0.43 | |
0.00 | 0.00 | 0.00 | -1.60 | -4.81 | |
0.00 | 0.00 | 0.00 | 8.79 | 5.21 | |
Net Cash Flow | -0.03 | -0.02 | 0.01 | 0.24 | -0.03 |
Ratios
Figures in Rs. Crores
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|
Debtor Days | 54.48 | 188.03 | 378.52 | 18.02 | 36.50 |
Inventory Days | 0.00 | 0.00 | 158.70 | 14.29 | 59.59 |
Days Payable | 380.87 | 41.78 | 55.87 | ||
Cash Conversion Cycle | 54.48 | 188.03 | 156.34 | -9.46 | 40.22 |
Working Capital Days | 76.27 | 210.15 | 216.30 | 603.83 | 1,257.22 |
ROCE % | 9.76% | 4.35% | 2.14% | 2.63% |
Documents
Announcements
- Compliance Certificate - Regulation 7 (3) Of SEBI (LODR) Regulations, 2015. For The Year 01/04/2023 To 31/03/2024 12 Apr
- Submission Of Share Transfer Etc. Certificate For The Year Ended 31St March 2024, Pursuant To Regulation 40(10) Of The SEBI (LODR ) 2015. 11 Apr
- Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 11 Apr
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
11 Apr - Certificate under Regulation 74(5) of SEBI DP Regulation for the quarter ended 31st March, 2024.
- Closure of Trading Window 29 Mar
Business Overview:[1]
Company is in the manufacturing of
pharmaceutical formulations in the
forms of Tablets, Capsules, Oral liquid
and Injectables.